TRIEU VUONG (CEO and Chairman of the Board) purchased 0.1% of their position (126.89K shares) of ONCOTELIC THERAPEUTICS, INC. on the open market
Open‑market purchase worth $4.3K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/31/2023ACC: 0001493152-23-019557
DirectorOfficer10% Owner· CEO and Chairman of the Board
Since Apr 2019
+126.89K
Net shares
Net buyer
$4.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
126.89K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+126.89K
Price / share
$0.03
Trade value
$4.33K
% of position
0.1%
5/26/2023
90.92M→91.04M
Total
Net shares
+126.89K
Net value
$4.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/26/2023 | P · Purchase | +126.89K | $0.03 | $4.33K | 0.1% | 90.92M | 91.04M |
| Total | +126.89K | $4.33K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned6.87M
Common Stock
IndirectShares owned16.78M
Total
23.65M indirect23.65M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.87M | Indirect |
| Common Stock | 16.78M | Indirect |
| Total | 23.65M | 23.65M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported